Page 10 - Riccardo Canevari News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Radiopharm Theranostics Ltd inks Lantheus strategic collaboration; secures NM-01 licensing agreement with Nanomab

Radiopharm Theranostics Ltd inks Lantheus strategic collaboration; secures NM-01 licensing agreement with Nanomab
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Radiopharm theranosticsRiccardo canevariEtienne montagutDrug administrationRadiopharm theranostics ltd

Radiopharm Theranostics announces new agreements with Lantheus and NanoMab

Radiopharm Theranostics announces new agreements with Lantheus and NanoMab
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Riccardo canevariEtienne montagutRadiopharm theranostics

RADIOPHARM ENTERS INTO STRATEGIC COLLABORATION WITH LANTHEUS AND ASSUMES PD-L1 LICENSING AGREEMENT FROM NANOMAB

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesRadiopharm theranosticsPaul hopperPrnewswire radiopharm theranosticsRiccardo canevariEtienne montagutNanomab ltdDrug administrationUnited states foodDirector riccardo canevariChief business officerChairman paulPr newswireLicensing agreements

Radiopharm Theranostics Ltd extends agreement for Australian prostate cancer trial with GenesisCare

Radiopharm Theranostics Ltd (ASX:RAD) has opted to extend an agreement with global oncology provider GenesisCare to support a second Radioipharm clinical.

United statesUnited kingdomLos angelesDavid ulmertRadiopharm theranosticsRiccardo canevariSloan ketteringUniversity of californiaRadiopharm theranostics ltdProfessor david ulmertMemorial sloan kettering

Radiopharm Theranostics Ltd strengthens Scientific Advisory Board with highly credentialed professor

Radiopharm Theranostics Ltd (ASX:RAD) has strengthened its advisory credentials with the appointment of Dr Susann Brady-Kalnay PhD to its Scientific.

Sara hurvitzDavid ulmertEric aboagyeRadiopharm theranosticsRiccardo canevariJohannes notniDavid mozleyCase comprehensive cancer centerNational cancer instituteNational institutes of healthRadiopharm theranostics ltdAcademic industrial partnershipScientific advisory boardMolecular biologyCase western reserve universitySusann brady kalnay phd